Skip to content

Effect of different doses of esketamine combined with propofol and sufentanil on intraocular pressure during general anesthesia induction period in pediatric strabismus surgery

Effect of different doses of esketamine combined with propofol and sufentanil on intraocular pressure during general anesthesia induction period in pediatric strabismus surgery

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200066586
Enrollment
Unknown
Registered
2022-12-09
Start date
2022-12-30
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia for strabismus surgery

Interventions

Normal saline group:induction by Propofol+sufentanil+normal saline
Esketamine 0.25mg/Kg group:induction by Propofol+sufentanil+esketamine 0.25mg/Kg
esketamine 0.5mg/Kg group:induction by Propofol+sufentanil+esketamine 0.5mg/Kg

Sponsors

Tianjin Eye Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
7 Years to 13 Years

Inclusion criteria

Inclusion criteria: ? ASA grade I - II; ? Age 7-12 years; ? Children undergoing strabismus surgery under general anesthesia; ? The family members of the child are informed and sign the informed consent form

Exclusion criteria

Exclusion criteria: ? Children with glaucoma, keratopathy, retinopathy and neuromuscular disease history, upper respiratory tract infection or difficult airway within two weeks before operation; ? Children with allergy to drugs that affect intraocular pressure, related general anesthesia and local anesthetic drugs used within 2 days before operation; ? Children unable to measure intraocular pressure under topical anesthesia before anesthesia

Design outcomes

Primary

MeasureTime frame
introcular pressure;

Secondary

MeasureTime frame
blood pressure;heart rate;

Countries

China

Contacts

Public ContactLuo jun

Tianjin Eye Hospital

jeff_8225@163.com+86 18602630086

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 8, 2026